Items where Author is "Richter, Michael"

Article

Iwanow, Melanie and Seidler, Johannes and Vieira, Luciana and Kaiser, Manuela and Van Opdenbosch, Daniel and Zollfrank, Cordt and Gaertner, Tobias and Richter, Michael and Koenig, Burkhard and Sieber, Volker (2021) Enhanced C2 and C3 Product Selectivity in Electrochemical CO2 Reduction on Carbon-Doped Copper Oxide Catalysts Prepared by Deep Eutectic Solvent Calcination. CATALYSTS, 11 (5): 542. ISSN 2073-4344

Iwanow, Melanie and Vieira, Luciana and Rud, Igor and Seidler, Johannes and Kaiser, Manuela and Van Opdenbosch, Daniel and Zollfrank, Cordt and Richter, Michael and Gaertner, Tobias and Koenig, Burkhard and Sieber, Volker (2020) Pyrolysis of Deep Eutectic Solvents for the Preparation of Supported Copper Electrocatalysts. CHEMISTRYSELECT, 5 (38). pp. 11714-11720. ISSN 2365-6549

Kuhnt, Thomas and Schreiber, Andreas and Pirnasch, Anett and Hautmann, Matthias G. and Hass, Peter and Sieker, Frank P. and Engenhart-Cabillic, Rita and Richter, Michael and Dellas, Kathrin and Dunst, Juergen (2017) Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck. STRAHLENTHERAPIE UND ONKOLOGIE, 193 (9). pp. 733-741. ISSN 0179-7158, 1439-099X

Stein, Alexander and Glockzin, Gabriel and Wienke, Andreas and Arnold, Dirk and Edelmann, Thomas and Hildebrandt, Bert and Hollerbach, Stephan and Illerhaus, Gerald and Koenigsrainer, Alfred and Richter, Michael and Schlitt, Hans J. and Schmoll, Hans-Joachim (2012) Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature. BMC CANCER, 12: 356. ISSN 1471-2407

Other

Kuhnt, Thomas and Schreiber, Andreas and Pirnasch, Anett and Hautmann, Matthias and Hass, Peter and Sieker, Frank and Engenhart-Cabilic, Rita and Richter, Michael and Dellas, Kathrin and Dunst, Juergen (2013) Phase II trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell carcinoma of the head and neck (LA SCCHN): Feasibility and 2-year OS. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.